371 related articles for article (PubMed ID: 33953728)
1. Neoepitopes in Type 1 Diabetes: Etiological Insights, Biomarkers and Therapeutic Targets.
Rodriguez-Calvo T; Johnson JD; Overbergh L; Dunne JL
Front Immunol; 2021; 12():667989. PubMed ID: 33953728
[TBL] [Abstract][Full Text] [Related]
2. Post-translational modifications contribute to neoepitopes in Type-1 diabetes: Challenges for inducing antigen-specific tolerance.
Balakrishnan S; Kumar P; Prabhakar BS
Biochim Biophys Acta Proteins Proteom; 2020 Oct; 1868(10):140478. PubMed ID: 32599298
[TBL] [Abstract][Full Text] [Related]
3. Immune Recognition of β-Cells: Neoepitopes as Key Players in the Loss of Tolerance.
James EA; Pietropaolo M; Mamula MJ
Diabetes; 2018 Jun; 67(6):1035-1042. PubMed ID: 29784651
[TBL] [Abstract][Full Text] [Related]
4. Autoreactive T cells in type 1 diabetes.
Pugliese A
J Clin Invest; 2017 Aug; 127(8):2881-2891. PubMed ID: 28762987
[TBL] [Abstract][Full Text] [Related]
5. A roadmap of the generation of neoantigens as targets of the immune system in type 1 diabetes.
Roep BO; Kracht MJ; van Lummel M; Zaldumbide A
Curr Opin Immunol; 2016 Dec; 43():67-73. PubMed ID: 27723537
[TBL] [Abstract][Full Text] [Related]
6. Identifying New Hybrid Insulin Peptides (HIPs) in Type 1 Diabetes.
Mannering SI; Rubin AF; Wang R; Bhattacharjee P
Front Immunol; 2021; 12():667870. PubMed ID: 33995402
[TBL] [Abstract][Full Text] [Related]
7. The beta-cell in type 1 diabetes: What have we learned from proteomic studies?
Crèvecoeur I; Rondas D; Mathieu C; Overbergh L
Proteomics Clin Appl; 2015 Aug; 9(7-8):755-66. PubMed ID: 25641783
[TBL] [Abstract][Full Text] [Related]
8. Mapping T Cell Responses to Native and Neo-Islet Antigen Epitopes in at Risk and Type 1 Diabetes Subjects.
Arif S; Pujol-Autonell I; Kamra Y; Williams E; Yusuf N; Domingo-Vila C; Shahrabi Y; Pollock E; Khatri L; Peakman M; Tree T; Lorenc A
Front Immunol; 2021; 12():675746. PubMed ID: 34262563
[TBL] [Abstract][Full Text] [Related]
9. Neoantigens and Microenvironment in Type 1 Diabetes: Lessons from Antitumor Immunity.
Kracht MJL; Zaldumbide A; Roep BO
Trends Endocrinol Metab; 2016 Jun; 27(6):353-362. PubMed ID: 27094501
[TBL] [Abstract][Full Text] [Related]
10. Citrullination and PAD Enzyme Biology in Type 1 Diabetes - Regulators of Inflammation, Autoimmunity, and Pathology.
Yang ML; Sodré FMC; Mamula MJ; Overbergh L
Front Immunol; 2021; 12():678953. PubMed ID: 34140951
[TBL] [Abstract][Full Text] [Related]
11. Neoepitopes: a new take on beta cell autoimmunity in type 1 diabetes.
Mannering SI; Di Carluccio AR; Elso CM
Diabetologia; 2019 Mar; 62(3):351-356. PubMed ID: 30402774
[TBL] [Abstract][Full Text] [Related]
12. Endoplasmic Reticulum-Mitochondria Crosstalk and Beta-Cell Destruction in Type 1 Diabetes.
Vig S; Lambooij JM; Zaldumbide A; Guigas B
Front Immunol; 2021; 12():669492. PubMed ID: 33936111
[TBL] [Abstract][Full Text] [Related]
13. Autoantigen-specific memory CD4+ T cells are prevalent early in progression to Type 1 diabetes.
Oling V; Reijonen H; Simell O; Knip M; Ilonen J
Cell Immunol; 2012; 273(2):133-9. PubMed ID: 22270037
[TBL] [Abstract][Full Text] [Related]
14. Modifying Enzymes Are Elicited by ER Stress, Generating Epitopes That Are Selectively Recognized by CD4
Marre ML; McGinty JW; Chow IT; DeNicola ME; Beck NW; Kent SC; Powers AC; Bottino R; Harlan DM; Greenbaum CJ; Kwok WW; Piganelli JD; James EA
Diabetes; 2018 Jul; 67(7):1356-1368. PubMed ID: 29654212
[TBL] [Abstract][Full Text] [Related]
15. Inherent ER stress in pancreatic islet β cells causes self-recognition by autoreactive T cells in type 1 diabetes.
Marré ML; Profozich JL; Coneybeer JT; Geng X; Bertera S; Ford MJ; Trucco M; Piganelli JD
J Autoimmun; 2016 Aug; 72():33-46. PubMed ID: 27173406
[TBL] [Abstract][Full Text] [Related]
16. How apoptotic β-cells direct immune response to tolerance or to autoimmune diabetes: a review.
Vives-Pi M; Rodríguez-Fernández S; Pujol-Autonell I
Apoptosis; 2015 Mar; 20(3):263-72. PubMed ID: 25604067
[TBL] [Abstract][Full Text] [Related]
17. Protective role of anti-idiotypic antibodies in autoimmunity--lessons for type 1 diabetes.
Hampe CS
Autoimmunity; 2012 Jun; 45(4):320-31. PubMed ID: 22288464
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of NOD diabetes is initiated by reactivity to the insulin B chain 9-23 epitope and involves functional epitope spreading.
Prasad S; Kohm AP; McMahon JS; Luo X; Miller SD
J Autoimmun; 2012 Dec; 39(4):347-53. PubMed ID: 22647732
[TBL] [Abstract][Full Text] [Related]
19. T cell recognition of autoantigens in human type 1 diabetes: clinical perspectives.
Mallone R; Brezar V; Boitard C
Clin Dev Immunol; 2011; 2011():513210. PubMed ID: 21785617
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms in autoimmune type 1 diabetes: a critical review.
Xie Z; Chang C; Zhou Z
Clin Rev Allergy Immunol; 2014 Oct; 47(2):174-92. PubMed ID: 24752371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]